US Patent

US10912772 — Opioid formulations

Method of Use · Assigned to Camurus AB · Expires 2032-07-26 · 6y remaining

Vulnerability score 70/100 Vulnerable — likely target for IPR or design-around

What this patent protects

This patent provides depot compositions and methods of treatment for pain management using opioid maintenance and related methods.

USPTO Abstract

Corresponding depot compositions and methods of treatment in pain management, by opioid maintenance and related methods are provided.

Drugs covered by this patent

Subutex (BUPRENORPHINE) · Purdue Pharma Lp

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

Code	Description	Drug
`U-3617`	—	Subutex
`U-3617`	—	Subutex
`U-3617`	—	Subutex
`U-3617`	—	Subutex
`U-3617`	—	Subutex
`U-3617`	—	Subutex
`U-3617`	—	Subutex

Patent Metadata

Patent number: US10912772
Jurisdiction: US
Classification: Method of Use
Expires: 2032-07-26
Drug substance claim: No
Drug product claim: No
Assignee: Camurus AB
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.